Thanks, Gio. Turning to Page 6. This slide summarizes our fourth quarter financial results. We finished the year quite strong. Our organic net sales increased 12%, 5% from volume, 7% from price. And America continues to be the growth engine, which Americas was up 22% in the quarter. Our sales performance was within guidance range, but slightly below midpoint which was mainly attributable to a weaker China and some project delays in EMEA. Adjusted operating profit was $330 million, up $120 million from last year's fourth quarter and that was mainly driven by favorable price cost and the higher volume. We beat the midpoint of our implied fourth quarter adjusted operating profit guidance based upon good commercial execution and material inflation below our modeled assumptions. Our adjusted operating margin was 17.7% in the quarter, a 500-basis-point improvement compared to last year. And that certainly was driven by our continued relentless focus on operational execution, and that clearly showed in the results. As we move to the right, our fourth quarter GAAP diluted EPS includes a $115 million nonrecurring tax benefit related to the release of a valuation allowance, and we have removed that from adjusted diluted EPS. And we provide additional detail on that valuation allowance release on Page 28 in the appendix. But otherwise, the year-over-year increase in adjusted diluted EPS was driven by higher adjusted operating profit. To the far right, another very strong quarter for adjusted free cash flow as we generated $305 million in the quarter, more than doubling last year. Certainly, higher profitability contributed to this result, but working capital is also an important part of the story with plenty of opportunity for continued improvement. As Gio mentioned net leverage declined to 1.9x within our target long-term leverage range of 1 to 2x and down from 5.6x at the end of 2022. This leverage level supports the capital deployment framework provided at our investor conference and gives us significant flexibility and optionality to deploy excess cash. Turning to Page 7. This slide summarizes our fourth quarter segment results. The Americas region, as I mentioned, continues to fuel the growth engine with organic net sales up 22% in the quarter. The improvement in adjusted operating margin in the Americas continues, up 640 basis points from last year to 26.9%, with the increase primarily driven by favorable price cost and fixed cost leverage. APAC sales increased 3% organically, but continues to be weighed down by China, where sales were relatively flat year-over-year, but below expectations included in our quarterly guidance. APAC adjusted operating margin declined 220 points with unfavorable mix and the timing of fixed cost contributory factors. EMEA grew 1% organically in the fourth quarter, which was lower than anticipated primarily due to delays on several larger projects. However, we did see an 18% sequential sales increase from the third quarter, which is encouraging and EMEA experienced strong year-over-year fourth quarter orders growth, both which provides confidence for us to project low double-digit organic growth in EMEA for full year 2024. EMEA delivered strong adjusted operating margin of 28.3% in the fourth quarter, an increase of 750 basis points from last year's fourth quarter, although they did benefit from a $6 million nonrecurring gain from an asset sale in the quarter. And as Anand Sanghi, our Americas President, has emphatically reminded us, without that gain, the adjusted operating margin for the Americas and EMEA would have been approximately the same as those 2 regions continue to push each other for highest regional adjusted operating margin. Next, turning to Page 8, a summary of full year 2023. I can safely say it was a very strong year. It's always a good thing when the orange bars on this slide are significantly higher than the gray bars and that is the case for all financial metrics for this past year. 2023 produced a step function change in financial performance from 2022 that is not often seen in a 12-month period. This significant improvement is a result of a relentless focus on operational execution, which very clearly reads directly through -- to our financial results. Our full year organic sales up 21%, reflects a great position in a strong end market. Adjusted operating margin of 15.3%, an improvement of 760 basis points from last year, certainly provides a strong foundation to surpass our midterm adjusted operating margin target of 16%, which we expect to do in 2024, with about 110 basis points to spare at the midpoint. We did well in converting the improved profitability to cash with an over $1 billion improvement year-over-year. And let me repeat that, an over $1 billion improvement in adjusted free cash flow year-over-year, with this improvement driven by the higher profitability and improved working capital management while continuing to invest in CapEx to support growth. Adjusted free cash flow of $778 million drove an adjusted free cash flow conversion of 114%, with this improved conversion benefiting from a significant increase in deferred revenue primarily from advanced customer payments, which increased $280 million or 80% in the year, while sales were up 21%, which we estimate contributed about 30 percentage points to that conversion. While we expect continued growth in deferred revenue, there are many market dynamics at play, and we should not expect similar growth in 2024, which is one of the primary reasons we are guiding to adjusted free cash flow conversion in the low to mid-90s for full year 2024. We have much work to do, and there's plenty of opportunity for continued improvement, but 2023 certainly demonstrates our potential and helps build credibility and confidence that we can execute upon our long-term strategy and deliver the financial targets we introduced at our Investor Conference. Pivoting to 2024 and moving to Slide 9. This is a look at our first quarter guidance. We are expecting first quarter sales to be up approximately 5% organically with Americas up high single digits, APAC's up mid-single digits and EMEA relatively flat. Adjusted operating profit between $200 million and $220 million and adjusted operating margin of 13.1%, up 160 basis points from last year's first quarter. And that is driven by price/cost tailwinds and productivity programs, partially offset by continued growth investments. As you likely have noted in our slide deck, we have not provided the detailed split between price and cost/inflation for 2024. As we emphasized at our Investor Conference, our ambition is to cover all inflation, including labor inflation with price and being price cost positive is an important lever for us to attain our long-term adjusted operating margin target of 20% plus. As you will see on the next slide, we fully expect to be price/cost positive in 2024, and we expect that to be the case each year going forward. We will continue to price our products commensurate with the increasing value we provide our customers. However, for commercial and competitive reasons, we are not disclosing the specific quantified pricing figure going forward, but rest assured, that commercial excellence actions are a core tenet to our continued profit improvement program, and we believe we are well positioned in a favorable market to continue to execute upon our long-term plans. Next, turning to Slide 10, our full year guidance, higher across all metrics from the view presented at our November Investor Conference. Organic net sales growth is expected to be 9% to 11%, up from the 8% to 10% we shared in November. We are increasing the midpoint for adjusted operating profit from $1.25 billion to $1.3 billion with adjusted operating margin at 17.1%, well above the previously established midterm target of 16%. And as a reminder, our long-term margin target is 20% plus, and we believe we will take all the necessary next steps in '24 on our path towards that target. Our projected 2024 adjusted diluted EPS of $2.23 at the midpoint is approximately 25% higher than 2023, primarily driven by higher adjusted operating profit and partially offset by taxes and a higher share count as the higher share price drives more accounting dilution for employee stock options. We have included some estimates for share repurchases and share price in our estimated '24 diluted share count, but we are not prepared at this point to share specifics for either but we believe the 393 million shares estimate for full year diluted share count is a reasonable and balanced guidance, but certainly subject to change based upon several variables. Moving to the right on this slide. We are projecting adjusted free cash flow between $800 million and $850 million, representing 94% adjusted free cash flow conversion at the midpoint. As mentioned, this is lower than 2023 conversion primarily due to assumptions with deferred revenue and higher investment in CapEx. And finally, as we introduced at our Investor Conference, there will be a couple of external reporting changes in 2024 to align with how we run the business. We summarized these changes on Slide 31 in the appendix, and we have provided a historical recasting for these changes going back to 2020 in Exhibit 99.2 of our earnings release. And with that said, I turn it back over to Gio.